Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells.
Buddingh EP, Schilham MW, Ruslan SE, Berghuis D, Szuhai K, Suurmond J, Taminiau AH, Gelderblom H, Egeler RM, Serra M, Hogendoorn PC, Lankester AC.
Buddingh EP, et al. Among authors: egeler rm.
Cancer Immunol Immunother. 2011 Apr;60(4):575-86. doi: 10.1007/s00262-010-0965-3. Epub 2011 Jan 15.
Cancer Immunol Immunother. 2011.
PMID: 21240486
Free PMC article.